Peter Chedraui
← Back to Universidad Espíritu Santo
Universidad Espíritu Santo
Peter Chedraui works in Menopause: Health Impacts and Treatments, Sexual function and dysfunction studies, Ovarian function and disorders, Adrenal Hormones and Disorders, Diabetes, Cardiovascular Risks, and Lipoproteins. Recorded institutional associations include Universidade de São Paulo, Universidad Espíritu Santo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
The Impact of the Menopausal Transition on Body Composition and Abdominal Fat Redistribution
2026 · 10 citationsGut microbiota and metabolic syndrome in postmenopausal women: a narrative review of mechanisms and dietary recommendations
2026 · 4 citationsDo menopausal symptoms signal early biological aging? Mitochondrial, endocrine and clinical insights
2026 · 3 citationsSeverity of menopausal symptoms is associated with lower work-related quality of life and job satisfaction in midlife Latin American women: REDLINC XIII
2026 · 2 citationsMelatonin Enhances Glutathione Peroxidase Activity and Improves Antioxidant Defense in Cryopreserved Ovarian Transplants: A Rat Model Study
2026 · 2 citationsPhysical activity as an alternative or adjunct to menopausal hormone therapy for symptom management in women with primary ovarian insufficiency
2026 · 1 citationsFrozen-Thawed ovarian autografts treated with scaffold-based melatonin delivery in rats
2026 · 1 citationsEndometriosis beyond menopause: a call for greater clinical awareness
2026 · 1 citationsUric Acid–to–HDL cholesterol ratio and probable MASLD across adiposity strata in postmenopausal women
2026 · 1 citationsHot flashes: a potential marker of deterioration of health-related quality of life
2026 · 0 citationsImpaired quality of life among middle aged women: Amulticentre Latin American study
2008 · 0 citationsMigraine Throughout Women’s Reproductive Life: Unravelling the Cardiovascular and Metabolic Implications
2026 · 0 citationsDrawbacks in dopaminergic neurotransmission: compromising sexual performance
2026 · 0 citationsFrom ‘polycystic ovary syndrome’ to ‘polyendocrine metabolic ovarian syndrome’: why terminology matters
2026 · 0 citationsFDA safety concerns and menopausal-like symptoms in postmenopausal statin users
2026 · 0 citationsHormonal and metabolic effects of the administration of oral low-dose 17-β-estradiol (0.2 mg) in patients with functional hypothalamic amenorrhea: a retrospective pilot study
2026 · 0 citationsPerimenopausal symptom burden: implications for health, work and earlier clinical management
2026 · 0 citationsCombined treatment with L-Glutathione, D-Chiro-Inositol, Myo-inositol and N-Acetylcysteine reduces insulin resistance in overweight/obese patients with polycystic ovary syndrome
2026 · 0 citationsDydrogesterone and inflammatory marker regulation: a systematic review and quantitative meta-analysis
2026 · 0 citationsAssociation of statin use with severe urogenital symptoms and lower sexual function in postmenopausal women: a cross-sectional study
2026 · 0 citations
